ArticleFrontiers in neuroscience2026

Retraction: Observations on the efficacy of edaravone dexborneol in preventing post-stroke depression and its inflammatory mechanism: a prospective, randomized, control trial.

Frontiers Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.